PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1270346
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1270346
NGS Sample Preparation Market size was valued at USD 2,306.8 million in 2022, expanding at a CAGR of 11.8% from 2023 to 2030.
A crucial step in the field of genomics is the preparation of NGS (Next-generation sequencing) samples, which entails transforming biological samples into a format appropriate for sequencing. The NGS sample preparation industry offers a range of goods and services, including DNA fragmentation, target enrichment, library preparation, and quality control.
NGS Sample Preparation Market- Market Dynamics
The factor influencing the market for NGS sample preparation is the rise in global genomic research projects. Genetic research is becoming more and more popular because it can offer in-depth knowledge of biology, human history, and health inequities as well as the identification of various important clinical consequences. Exome and genome sequencing have lately made widespread genetic testing on an individual patient basis within a clinically meaningful timeframe possible thanks to advancements in sequencing technology. As a result, NGS is essential for the diagnosis and monitoring of a variety of infectious illnesses, which could fuel the growth of the NGS Sample Preparation market.
The development of NGS Sample Preparation has been significantly hampered by the dearth of knowledge about its application in the healthcare sector. End consumers in the healthcare sector are still unsure of the advantages of this cutting-edge technology and how it operates. Because of this, businesses might be reluctant to make investments in this quickly evolving technology. Investors, the general public, and entrepreneurs have yet to fully grasp its potential to revolutionize business processes. A major obstacle to the adoption of NGS Sample Preparation is a lack of knowledge and general awareness. NGS Sample Preparation will be more crucial in the future due to its rising popularity and comprehension.
The Global NGS Sample Preparation Market is segmented based on product Class, application, End-user, and Region.
Based on the application, the drug discovery segment is expected to dominate the market during the forecast period. This is due to a number of companies are collaborating to build precise NGS libraries that will use the right lab chemicals to produce the best results from sequencing. For instance, in September 2022, QIAGEN and Neuron23 collaborated on the development of NGS-based companion diagnostics utilizing Leucine-Rich Repeat Kinase Inhibitor, a patented drug from Neuron23 that is a brain penetrant used to treat Parkinson's disease. Together with comprehensive support for medication development, Qiagen will create and validate a clinical trial assay that would essentially identify the combination of biomarkers discovered by Neuron23.
NGS Sample Preparation Market- Geographical Insights
North America is expected to have a large market share in the NGS Sample Preparation Market owing to the widespread presence of instruments for diagnosing health inequities, as well as the region's growing burden of chronic diseases and infectious diseases. For instance, in January 2022, in a multi-year agreement, Illumina Inc. and Nashville Biosciences LLC, a division of Vanderbilt University Medical Center (VUMC), agreed to use Illumina's next-generation sequencing (NGS) platforms to accelerate the development of new medicines through large-scale genomics and the creation of a clinical-genomic resource. These programs are anticipated to fuel the market for NGS sample preparation in North America.
In September 2022, Illumina Inc. unveiled its next-generation NovaSeq X systems, which can produce 2.5 times as many whole genomes (more than 20,000) annually than earlier sequencers.
In August 2022, with the introduction of the QIAseq UPXome RNA Library Kit and QIAseq Targeted DNA Pro Panels, QIAGEN increased the scope of its next-generation sequencing (NGS) offerings. Both have established new benchmarks for collecting samples in order to identify their nucleic acid sequences.
This proposed research study on the NGS Sample Preparation Market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for NGS Sample Preparation Market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the NGS Sample Preparation Market
Impact of COVID-19 on NGS Sample Preparation Market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on NGS Sample Preparation Market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the NGS Sample Preparation Market, we have also included competitive landscape and key innovator analysis for the NGS Sample Preparation Market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the NGS Sample Preparation Market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global NGS Sample Preparation Market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
GLOBAL NGS SAMPLE PREPARATION MARKET KEY PLAYERS
Integrated DNA Technologies
F. Hoffmann-La Roche AG, Inc.
Beckman Coulter Inc. (Danaher Corporation)
Agilent Technologies, Inc.
Tecan Group Ltd.
PerkinElmer Inc.
Illumina, Inc.
QIAGEN N.V.
Dickinson and Company
Becton
Merck KGaA
New England Biolabs Inc.
Pacific Biosciences of California, Inc.
Thermo Fisher Scientific Inc.
GLOBAL NGS SAMPLE PREPARATION MARKET, BY PRODUCT CLASS
Reagent and Consumables
Workstations
GLOBAL NGS SAMPLE PREPARATION MARKET, BY APPLICATION
Diagnostics
Drug Discovery
Other Applications
GLOBAL NGS SAMPLE PREPARATION MARKET, BY END-USER
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End Users
GLOBAL NGS SAMPLE PREPARATION MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA